nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Cisplatin—testicular cancer	0.128	0.168	CbGbCtD
Sildenafil—ABCC10—Etoposide—testicular cancer	0.126	0.165	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—testicular cancer	0.0861	0.112	CbGbCtD
Sildenafil—ABCC10—Methotrexate—testicular cancer	0.0834	0.109	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0504	0.0657	CbGbCtD
Sildenafil—CYP3A7—Ifosfamide—testicular cancer	0.0504	0.0657	CbGbCtD
Sildenafil—ABCC4—Methotrexate—testicular cancer	0.0401	0.0523	CbGbCtD
Sildenafil—CYP3A5—Ifosfamide—testicular cancer	0.0378	0.0493	CbGbCtD
Sildenafil—CYP2C19—Ifosfamide—testicular cancer	0.0305	0.0398	CbGbCtD
Sildenafil—CYP2C9—Ifosfamide—testicular cancer	0.0254	0.0331	CbGbCtD
Sildenafil—CYP2E1—Etoposide—testicular cancer	0.0233	0.0303	CbGbCtD
Sildenafil—CYP3A5—Etoposide—testicular cancer	0.0181	0.0236	CbGbCtD
Sildenafil—CYP3A4—Ifosfamide—testicular cancer	0.0147	0.0192	CbGbCtD
Sildenafil—CYP2C9—Cisplatin—testicular cancer	0.0123	0.0161	CbGbCtD
Sildenafil—CYP2D6—Vinblastine—testicular cancer	0.0123	0.016	CbGbCtD
Sildenafil—CYP3A4—Vinblastine—testicular cancer	0.00782	0.0102	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—testicular cancer	0.00756	0.00986	CbGbCtD
Sildenafil—CYP3A4—Etoposide—testicular cancer	0.00704	0.00919	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—testicular cancer	0.00481	0.00627	CbGbCtD
Sildenafil—PDE6G—testis—testicular cancer	0.00124	0.108	CbGeAlD
Sildenafil—PDE6G—lymph node—testicular cancer	0.000902	0.0784	CbGeAlD
Sildenafil—ADORA2A—gonad—testicular cancer	0.000749	0.0651	CbGeAlD
Sildenafil—ABCC10—seminal vesicle—testicular cancer	0.000721	0.0628	CbGeAlD
Sildenafil—PDE5A—gonad—testicular cancer	0.000682	0.0593	CbGeAlD
Sildenafil—PDE5A—female gonad—testicular cancer	0.000554	0.0482	CbGeAlD
Sildenafil—ADORA2A—testis—testicular cancer	0.00054	0.047	CbGeAlD
Sildenafil—ABCC10—gonad—testicular cancer	0.000521	0.0453	CbGeAlD
Sildenafil—ABCC5—female gonad—testicular cancer	0.000507	0.0441	CbGeAlD
Sildenafil—PDE5A—testis—testicular cancer	0.000492	0.0428	CbGeAlD
Sildenafil—ABCC5—testis—testicular cancer	0.00045	0.0391	CbGeAlD
Sildenafil—ABCC10—female gonad—testicular cancer	0.000424	0.0369	CbGeAlD
Sildenafil—ABCC10—testis—testicular cancer	0.000376	0.0327	CbGeAlD
Sildenafil—CYP2E1—seminal vesicle—testicular cancer	0.000366	0.0318	CbGeAlD
Sildenafil—PDE5A—lymph node—testicular cancer	0.000356	0.031	CbGeAlD
Sildenafil—ABCC4—female gonad—testicular cancer	0.000351	0.0306	CbGeAlD
Sildenafil—ABCC5—lymph node—testicular cancer	0.000326	0.0284	CbGeAlD
Sildenafil—ABCC4—testis—testicular cancer	0.000312	0.0271	CbGeAlD
Sildenafil—ABCC10—lymph node—testicular cancer	0.000272	0.0237	CbGeAlD
Sildenafil—CYP1A1—female gonad—testicular cancer	0.000235	0.0205	CbGeAlD
Sildenafil—CYP3A5—female gonad—testicular cancer	0.00023	0.02	CbGeAlD
Sildenafil—ABCC4—lymph node—testicular cancer	0.000226	0.0197	CbGeAlD
Sildenafil—CYP2E1—testis—testicular cancer	0.00019	0.0166	CbGeAlD
Sildenafil—CYP2D6—female gonad—testicular cancer	0.00017	0.0148	CbGeAlD
Sildenafil—CYP1A1—lymph node—testicular cancer	0.000151	0.0132	CbGeAlD
Sildenafil—CYP2D6—testis—testicular cancer	0.000151	0.0131	CbGeAlD
Sildenafil—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000121	0.000547	CcSEcCtD
Sildenafil—Urticaria—Etoposide—testicular cancer	0.000121	0.000545	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—testicular cancer	0.000121	0.000544	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—testicular cancer	0.000121	0.000544	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—testicular cancer	0.00012	0.000543	CcSEcCtD
Sildenafil—Abdominal pain—Etoposide—testicular cancer	0.00012	0.000543	CcSEcCtD
Sildenafil—Body temperature increased—Etoposide—testicular cancer	0.00012	0.000543	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—testicular cancer	0.00012	0.000543	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—testicular cancer	0.00012	0.000543	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—testicular cancer	0.00012	0.000542	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—testicular cancer	0.00012	0.000541	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—testicular cancer	0.00012	0.00054	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—testicular cancer	0.00012	0.000539	CcSEcCtD
Sildenafil—Asthenia—Cisplatin—testicular cancer	0.000119	0.000538	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—testicular cancer	0.000119	0.000537	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—testicular cancer	0.000119	0.000537	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—testicular cancer	0.000119	0.000535	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—testicular cancer	0.000119	0.000535	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—testicular cancer	0.000118	0.000534	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—testicular cancer	0.000118	0.000532	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—testicular cancer	0.000118	0.000532	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—testicular cancer	0.000118	0.000531	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—testicular cancer	0.000117	0.000526	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—testicular cancer	0.000116	0.000525	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—testicular cancer	0.000116	0.000524	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—testicular cancer	0.000116	0.000523	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—testicular cancer	0.000116	0.000522	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—testicular cancer	0.000116	0.000522	CcSEcCtD
Sildenafil—Chills—Methotrexate—testicular cancer	0.000115	0.000519	CcSEcCtD
Sildenafil—Nausea—Ifosfamide—testicular cancer	0.000115	0.000516	CcSEcCtD
Sildenafil—Diarrhoea—Cisplatin—testicular cancer	0.000114	0.000513	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—testicular cancer	0.000114	0.000512	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—testicular cancer	0.000113	0.000511	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—testicular cancer	0.000112	0.000507	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—testicular cancer	0.000112	0.000506	CcSEcCtD
Sildenafil—Hypersensitivity—Etoposide—testicular cancer	0.000112	0.000506	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—testicular cancer	0.000112	0.000505	CcSEcCtD
Sildenafil—Erythema—Methotrexate—testicular cancer	0.000112	0.000504	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—testicular cancer	0.000112	0.000504	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—testicular cancer	0.000112	0.000504	CcSEcCtD
Sildenafil—Flushing—Epirubicin—testicular cancer	0.000112	0.000503	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—testicular cancer	0.000112	0.000503	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—testicular cancer	0.000111	0.000502	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—testicular cancer	0.000111	0.000501	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—testicular cancer	0.000111	0.000499	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—testicular cancer	0.00011	0.000497	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—testicular cancer	0.00011	0.000495	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—testicular cancer	0.00011	0.000494	CcSEcCtD
Sildenafil—Asthenia—Etoposide—testicular cancer	0.000109	0.000492	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—testicular cancer	0.000109	0.000492	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—testicular cancer	0.000109	0.000491	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—testicular cancer	0.000109	0.000491	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—testicular cancer	0.000109	0.000489	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—testicular cancer	0.000108	0.000488	CcSEcCtD
Sildenafil—Back pain—Methotrexate—testicular cancer	0.000108	0.000487	CcSEcCtD
Sildenafil—Chills—Epirubicin—testicular cancer	0.000108	0.000486	CcSEcCtD
Sildenafil—Pruritus—Etoposide—testicular cancer	0.000108	0.000486	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—testicular cancer	0.000107	0.000484	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—testicular cancer	0.000107	0.000483	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—testicular cancer	0.000106	0.000479	CcSEcCtD
Sildenafil—Vomiting—Cisplatin—testicular cancer	0.000106	0.000476	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—testicular cancer	0.000105	0.000475	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—testicular cancer	0.000105	0.000474	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—testicular cancer	0.000105	0.000474	CcSEcCtD
Sildenafil—Rash—Cisplatin—testicular cancer	0.000105	0.000472	CcSEcCtD
Sildenafil—Dermatitis—Cisplatin—testicular cancer	0.000105	0.000472	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—testicular cancer	0.000105	0.000471	CcSEcCtD
Sildenafil—Erythema—Epirubicin—testicular cancer	0.000105	0.000471	CcSEcCtD
Sildenafil—Diarrhoea—Etoposide—testicular cancer	0.000104	0.00047	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—testicular cancer	0.000104	0.000468	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—testicular cancer	0.000104	0.000467	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—testicular cancer	0.000104	0.000467	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—testicular cancer	0.000103	0.000466	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—testicular cancer	0.000103	0.000465	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—testicular cancer	0.000103	0.000465	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—testicular cancer	0.000103	0.000465	CcSEcCtD
Sildenafil—Tension—Epirubicin—testicular cancer	0.000103	0.000463	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—testicular cancer	0.000102	0.000458	CcSEcCtD
Sildenafil—Back pain—Epirubicin—testicular cancer	0.000101	0.000456	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—testicular cancer	0.000101	0.000455	CcSEcCtD
Sildenafil—Malaise—Methotrexate—testicular cancer	0.000101	0.000454	CcSEcCtD
Sildenafil—Dizziness—Etoposide—testicular cancer	0.000101	0.000454	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—testicular cancer	0.0001	0.000453	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—testicular cancer	0.0001	0.000453	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—testicular cancer	0.0001	0.000452	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—testicular cancer	0.0001	0.000451	CcSEcCtD
Sildenafil—Chills—Doxorubicin—testicular cancer	9.98e-05	0.00045	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—testicular cancer	9.93e-05	0.000448	CcSEcCtD
Sildenafil—Nausea—Cisplatin—testicular cancer	9.87e-05	0.000445	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—testicular cancer	9.86e-05	0.000444	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—testicular cancer	9.82e-05	0.000443	CcSEcCtD
Sildenafil—Cough—Methotrexate—testicular cancer	9.75e-05	0.00044	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—testicular cancer	9.74e-05	0.000439	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—testicular cancer	9.71e-05	0.000437	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—testicular cancer	9.68e-05	0.000436	CcSEcCtD
Sildenafil—Vomiting—Etoposide—testicular cancer	9.68e-05	0.000436	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—testicular cancer	9.68e-05	0.000436	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—testicular cancer	9.68e-05	0.000436	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—testicular cancer	9.67e-05	0.000436	CcSEcCtD
Sildenafil—Agitation—Epirubicin—testicular cancer	9.61e-05	0.000433	CcSEcCtD
Sildenafil—Rash—Etoposide—testicular cancer	9.6e-05	0.000433	CcSEcCtD
Sildenafil—Dermatitis—Etoposide—testicular cancer	9.59e-05	0.000432	CcSEcCtD
Sildenafil—Headache—Etoposide—testicular cancer	9.54e-05	0.00043	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—testicular cancer	9.54e-05	0.00043	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—testicular cancer	9.52e-05	0.000429	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—testicular cancer	9.52e-05	0.000429	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—testicular cancer	9.52e-05	0.000429	CcSEcCtD
Sildenafil—Tension—Doxorubicin—testicular cancer	9.5e-05	0.000428	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	9.45e-05	0.000426	CcSEcCtD
Sildenafil—Malaise—Epirubicin—testicular cancer	9.43e-05	0.000425	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—testicular cancer	9.4e-05	0.000424	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—testicular cancer	9.4e-05	0.000424	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—testicular cancer	9.4e-05	0.000424	CcSEcCtD
Sildenafil—Syncope—Epirubicin—testicular cancer	9.38e-05	0.000423	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—testicular cancer	9.36e-05	0.000422	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—testicular cancer	9.36e-05	0.000422	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—testicular cancer	9.24e-05	0.000417	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—testicular cancer	9.19e-05	0.000414	CcSEcCtD
Sildenafil—Cough—Epirubicin—testicular cancer	9.13e-05	0.000411	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—testicular cancer	9.12e-05	0.000411	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—testicular cancer	9.06e-05	0.000408	CcSEcCtD
Sildenafil—Infection—Methotrexate—testicular cancer	9.06e-05	0.000408	CcSEcCtD
Sildenafil—Nausea—Etoposide—testicular cancer	9.05e-05	0.000408	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—testicular cancer	9.03e-05	0.000407	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—testicular cancer	8.98e-05	0.000405	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—testicular cancer	8.95e-05	0.000403	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—testicular cancer	8.95e-05	0.000403	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—testicular cancer	8.91e-05	0.000401	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—testicular cancer	8.91e-05	0.000401	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—testicular cancer	8.91e-05	0.000401	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—testicular cancer	8.89e-05	0.000401	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—testicular cancer	8.87e-05	0.0004	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—testicular cancer	8.86e-05	0.000399	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	8.84e-05	0.000399	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—testicular cancer	8.82e-05	0.000397	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—testicular cancer	8.8e-05	0.000397	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—testicular cancer	8.73e-05	0.000393	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—testicular cancer	8.71e-05	0.000393	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—testicular cancer	8.7e-05	0.000392	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—testicular cancer	8.7e-05	0.000392	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—testicular cancer	8.68e-05	0.000391	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—testicular cancer	8.66e-05	0.00039	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—testicular cancer	8.55e-05	0.000385	CcSEcCtD
Sildenafil—Oedema—Epirubicin—testicular cancer	8.54e-05	0.000385	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—testicular cancer	8.52e-05	0.000384	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—testicular cancer	8.51e-05	0.000383	CcSEcCtD
Sildenafil—Infection—Epirubicin—testicular cancer	8.48e-05	0.000382	CcSEcCtD
Sildenafil—Cough—Doxorubicin—testicular cancer	8.45e-05	0.000381	CcSEcCtD
Sildenafil—Shock—Epirubicin—testicular cancer	8.4e-05	0.000379	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—testicular cancer	8.39e-05	0.000378	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—testicular cancer	8.37e-05	0.000377	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—testicular cancer	8.36e-05	0.000377	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—testicular cancer	8.33e-05	0.000376	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.31e-05	0.000375	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—testicular cancer	8.29e-05	0.000374	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—testicular cancer	8.25e-05	0.000372	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—testicular cancer	8.25e-05	0.000372	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—testicular cancer	8.24e-05	0.000371	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—testicular cancer	8.24e-05	0.000371	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—testicular cancer	8.24e-05	0.000371	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—testicular cancer	8.21e-05	0.00037	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—testicular cancer	8.19e-05	0.000369	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.18e-05	0.000369	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—testicular cancer	8.14e-05	0.000367	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—testicular cancer	8.14e-05	0.000367	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—testicular cancer	8.13e-05	0.000367	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—testicular cancer	8.11e-05	0.000366	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—testicular cancer	8.06e-05	0.000363	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—testicular cancer	8.03e-05	0.000362	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—testicular cancer	7.98e-05	0.00036	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—testicular cancer	7.93e-05	0.000357	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—testicular cancer	7.9e-05	0.000356	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—testicular cancer	7.88e-05	0.000355	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—testicular cancer	7.86e-05	0.000354	CcSEcCtD
Sildenafil—Infection—Doxorubicin—testicular cancer	7.85e-05	0.000354	CcSEcCtD
Sildenafil—Pain—Methotrexate—testicular cancer	7.8e-05	0.000352	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.78e-05	0.000351	CcSEcCtD
Sildenafil—Shock—Doxorubicin—testicular cancer	7.77e-05	0.00035	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—testicular cancer	7.75e-05	0.000349	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—testicular cancer	7.72e-05	0.000348	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—testicular cancer	7.71e-05	0.000347	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—testicular cancer	7.67e-05	0.000346	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—testicular cancer	7.67e-05	0.000345	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—testicular cancer	7.64e-05	0.000344	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—testicular cancer	7.61e-05	0.000343	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—testicular cancer	7.59e-05	0.000342	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—testicular cancer	7.53e-05	0.000339	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—testicular cancer	7.52e-05	0.000339	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—testicular cancer	7.51e-05	0.000339	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—testicular cancer	7.46e-05	0.000336	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—testicular cancer	7.42e-05	0.000334	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—testicular cancer	7.38e-05	0.000333	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—testicular cancer	7.37e-05	0.000332	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—testicular cancer	7.36e-05	0.000332	CcSEcCtD
Sildenafil—Constipation—Epirubicin—testicular cancer	7.3e-05	0.000329	CcSEcCtD
Sildenafil—Pain—Epirubicin—testicular cancer	7.3e-05	0.000329	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—testicular cancer	7.25e-05	0.000327	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—testicular cancer	7.21e-05	0.000325	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—testicular cancer	7.21e-05	0.000325	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.2e-05	0.000324	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—testicular cancer	7.14e-05	0.000322	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—testicular cancer	7.09e-05	0.00032	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—testicular cancer	7.04e-05	0.000317	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—testicular cancer	7.03e-05	0.000317	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—testicular cancer	7.02e-05	0.000316	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—testicular cancer	6.98e-05	0.000315	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—testicular cancer	6.95e-05	0.000313	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—testicular cancer	6.87e-05	0.000309	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.82e-05	0.000307	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—testicular cancer	6.81e-05	0.000307	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—testicular cancer	6.78e-05	0.000306	CcSEcCtD
Sildenafil—Pain—Doxorubicin—testicular cancer	6.75e-05	0.000304	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—testicular cancer	6.75e-05	0.000304	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—testicular cancer	6.75e-05	0.000304	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—testicular cancer	6.75e-05	0.000304	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—testicular cancer	6.72e-05	0.000303	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—testicular cancer	6.54e-05	0.000295	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—testicular cancer	6.51e-05	0.000293	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—testicular cancer	6.46e-05	0.000291	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—testicular cancer	6.45e-05	0.000291	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—testicular cancer	6.29e-05	0.000283	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—testicular cancer	6.28e-05	0.000283	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—testicular cancer	6.24e-05	0.000281	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—testicular cancer	6.24e-05	0.000281	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—testicular cancer	6.24e-05	0.000281	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—testicular cancer	6.13e-05	0.000276	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—testicular cancer	6.04e-05	0.000272	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—testicular cancer	6.03e-05	0.000272	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—testicular cancer	5.84e-05	0.000263	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—testicular cancer	5.82e-05	0.000262	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—testicular cancer	5.8e-05	0.000261	CcSEcCtD
Sildenafil—Rash—Methotrexate—testicular cancer	5.75e-05	0.000259	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—testicular cancer	5.75e-05	0.000259	CcSEcCtD
Sildenafil—Headache—Methotrexate—testicular cancer	5.71e-05	0.000258	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—testicular cancer	5.67e-05	0.000255	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—testicular cancer	5.65e-05	0.000254	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—testicular cancer	5.59e-05	0.000252	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—testicular cancer	5.43e-05	0.000245	CcSEcCtD
Sildenafil—Nausea—Methotrexate—testicular cancer	5.42e-05	0.000244	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—testicular cancer	5.4e-05	0.000244	CcSEcCtD
Sildenafil—Rash—Epirubicin—testicular cancer	5.38e-05	0.000243	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—testicular cancer	5.38e-05	0.000242	CcSEcCtD
Sildenafil—Headache—Epirubicin—testicular cancer	5.35e-05	0.000241	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—testicular cancer	5.22e-05	0.000235	CcSEcCtD
Sildenafil—Nausea—Epirubicin—testicular cancer	5.07e-05	0.000229	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—testicular cancer	5.02e-05	0.000226	CcSEcCtD
Sildenafil—Rash—Doxorubicin—testicular cancer	4.98e-05	0.000224	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—testicular cancer	4.98e-05	0.000224	CcSEcCtD
Sildenafil—Headache—Doxorubicin—testicular cancer	4.95e-05	0.000223	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—testicular cancer	4.69e-05	0.000211	CcSEcCtD
